Mortalidad intrahospitalaria por accidente cerebrovascular
- Published: 01 Aug 2013 Journal: Medicina (Buenos Aires) (issn: 1669-9106,
Copyright policy)
- Publisher: Fundación Revista Medicina
- 1
- 2
1. The World Health Report 2000. Health systems: improving performance. Geneva: World Health Organization, 2000. En: www.who.int/whr/2000/en/; consultado 15/8/2010.
2. World Health Organization. Global Burden of Diseased Deaths, Years of Life Lost and Years Lost Due to Di - sability. En: http://appswhoint/ghodata/?vid¼72063; consultado 26/8/2010.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
4. Sposato LA, Esnaola MM, Zamora R, Zurrú MC, Fustinoni O, Saposnik G. ReNACer Investigators and the Argentinian Neurological Society. Quality of ischemic stroke care in emerging countries: the Argentinian National Stroke Registry (ReNACer). Stroke 2008; 39: 3036-41.
5. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000; 2831151-8.
6. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology 1998; 50341-50.
7. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke. A randomized controlled trial. JAMA 1998; 279: 1265-72.
8. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK; Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group. Variables associated with 7-day, 30-day and 1-year fatality after ischemic stroke. Stroke 2008; 39: 2318-24.
9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classifica - tion of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
10. Rojas JI, Zurru MC, Patrucco L, Romano M, Riccio PM, Cristiano E. Registro de enfermedad cerebrovascular isquémica. Medicina (B Aires) 2006; 66: 547-51.
11. Rotta Escalante R, Lourido M, Melcón C, Curatolo L. Accidente Cerebrovascular en la Policlínica Bancaria: Registro de 1699 Eventos Consecutivos. Revista Neurológica Argentina 2003; 28: 91-95.
12. Retamal E, Castro A, Espinoza M, Veas E, Retamal J, González-Hernández J. Características clínicas de la enfermedad cerebrovascular aguda y factores asociados a mortalidad en el hospital de urgencia y asistencia pú- blica. Revista Memoriza.com 2010; 6: 32-39. En: www. memoriza.com/; consultado el 26/08/12.
13. Castañeda-Guarderas A, Beltrán-Ale G, Casma-Bustamante R, Ruiz-Grosso P, Málaga G. Registry of patients with stroke stated in a public hospital of Peru, 2000-2009. Rev Peru Med Exp Salud Publica 2011; 28: 623-7.
14. Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke 1996; 27: 1937-43. [OpenAIRE]
15. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172(danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998; 279: 1265-72.
- 1
- 2